A fourth SAA receptor has also been suggested: Tanis/SelS whose expression has been linked to glucose and triglyceride levels in an animal model of type 2 diabetes and metabolic syndrome Psammomys obesus[49], could be a candidate for the metabolic effects of SAA in human adipocytes. Here, SELENOS is linked to metabolic syndrome.